97 related articles for article (PubMed ID: 30124166)
1. Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma.
Wei L; He F; Zhang W; Chen W; Yu B
Biol Res; 2018 Aug; 51(1):26. PubMed ID: 30124166
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes in glioma CpG island methylator phenotype via network analysis of gene expression data.
Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z
Mol Med Rep; 2017 Dec; 16(6):9503-9511. PubMed ID: 29152649
[TBL] [Abstract][Full Text] [Related]
3. Investigation of MicroRNA and transcription factor mediated regulatory network for silicosis using systems biology approach.
Choudhari JK; Verma MK; Choubey J; Sahariah BP
Sci Rep; 2021 Jan; 11(1):1265. PubMed ID: 33446673
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease.
Wang M; Wang S; Li Y; Cai G; Cao M; Li L
Brain Behav; 2020 Jun; 10(6):e01610. PubMed ID: 32304290
[TBL] [Abstract][Full Text] [Related]
5. Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development.
Rouigari M; Dehbashi M; Ghaedi K; Pourhossein M
Cell J; 2018 Jul; 20(2):150-156. PubMed ID: 29633591
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Investigation and Contribution of Other Chromosomes Besides Chromosome 21 in the Risk of Down Syndrome Development.
Zamanian Azodi M; Rezaei Tavirani M; Rezaei Tavirani M; Rostami Nejad M
Basic Clin Neurosci; 2021; 12(1):79-88. PubMed ID: 33995930
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
8. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
[TBL] [Abstract][Full Text] [Related]
9. Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
Maxwell R; Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Bettegowda C; Jallo GI; Terezakis SA; Groves ML
World Neurosurg; 2018 Nov; 119():e1006-e1015. PubMed ID: 30138731
[TBL] [Abstract][Full Text] [Related]
10. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
[TBL] [Abstract][Full Text] [Related]
11. RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma.
Wang J; Xu C; Cheng Q; Zhao J; Wu S; Li W; Ma W; Liu C; Jiang X
Front Oncol; 2020; 10():823. PubMed ID: 32547950
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma.
Miguel Llordes G; Medina Pérez VM; Curto Simón B; Castells-Yus I; Vázquez Sufuentes S; Schuhmacher AJ
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629304
[No Abstract] [Full Text] [Related]
14. Prognostic and immunomodulatory roles of schizophrenia-associated genes HTR2A, COMT, and PRODH in pan-cancer analysis and glioma survival prediction model.
Shen J; Wang Q; Lu F; Xu H; Wang P; Feng Y
Front Immunol; 2023; 14():1201252. PubMed ID: 37564635
[TBL] [Abstract][Full Text] [Related]
15.
Xu L; Liu Z; Wang H; Lu J; Xu J; Meng Y; Huang K; Liu B
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980973
[TBL] [Abstract][Full Text] [Related]
16. Impact of the m.13513G>A Variant on the Functions of the OXPHOS System and Cell Retrograde Signaling.
Kidere D; Zayakin P; Livcane D; Makrecka-Kuka M; Stavusis J; Lace B; Lin TK; Liou CW; Inashkina I
Curr Issues Mol Biol; 2023 Feb; 45(3):1794-1809. PubMed ID: 36975485
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
[TBL] [Abstract][Full Text] [Related]
18. Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer.
Tang S; Liu D; Fang Y; Yong L; Zhang Y; Guan M; Lin X; Wang H; Cai F
Front Oncol; 2023; 13():1080910. PubMed ID: 36816977
[TBL] [Abstract][Full Text] [Related]
19. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications.
Chen S; Deng X; Sheng H; Rong Y; Zheng Y; Zhang Y; Lin J
Mol Ther Nucleic Acids; 2021 Dec; 26():417-431. PubMed ID: 34552822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
